What This Top Dividend Portfolio Is Holding Now: AstraZeneca plc, HSBC Holdings plc And Vodafone Group plc

HSBC Holdings plc (LON:HSBA), AstraZeneca plc (LON:AZN) and Vodafone Group plc (LON:VOD) are heavyweight holdings of JP Morgan Claverhouse Investment Trust (LON:JCH).

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

JP Morgan Claverhouse IT (LSE: JCH) has a record of 41 consecutive years of dividend increases. At a current share price of 582p, the trust is on a trailing yield of 3.4%.

Picking great dividend shares has helped JP Morgan Claverhouse outperform the FTSE All-Share Index over the past three, five and 10 years.

Sectors in which the trust is currently overweight against the index include financials, healthcare and telecoms. The trust’s three biggest holdings in these three sectors are: HSBC (LSE: HSBA) (NYSE: HSBC.US), AstraZeneca (LSE: AZN) and Vodafone (LSE: VOD).

HSBC

Banking giant HSBC may have ditched its advertising slogan “The World’s Local Bank” a couple of years ago, but it has remained a convenient tag for financial hacks like me to emphasise the group’s global reach.

Geographical diversification helped HSBC get through the 2008/9 financial crisis. And while the company did reduce its dividend during those dark days, the payout has been growing at a good clip since, including a 9% rise for 2013.

City analysts are expecting a more modest 4% increase this year, followed by a 7% uplift for 2015. The recent market sell-off has seen HSBC’s shares hit a 52-week low of 589p, pushing the forward dividend yield up to a juicy 5.5% for investors today.

AstraZeneca

It’s been a good year for shareholders of AstraZeneca. The shares, which started the year at 3,600p, are currently trading at 4,427p on the back of the company’s strengthening drugs pipeline and management’s confident rejection of a 5,500p takeover offer from US pharma giant Pfizer.

The improving outlook hasn’t yet fed through to a rising dividend. Analysts are expecting the 2014 payout to be pegged at $2.80 for a fourth consecutive year, and for there to be little, if any, increase in 2015.

Nevertheless, the sterling translation of the dollar dividend equates to a yield of 4%, which is comfortably above the FTSE 100 average of 3.5%. And we could see the payout begin to rise pretty strongly further down the line.

Vodafone

Vodafone has been in a period of transition since selling its stake in US phones firm Verizon Wireless to Verizon Communications for £84bn earlier this year. The mobile giant’s earnings won’t — for at least a couple of years — cover the rising dividends the company hopes to pay.

Nevertheless, management reckons it can afford to lift the annual payouts, and signalled its confidence by raising the company’s recent interim dividend by 2%. If that carries through to the final dividend, as City analysts expect, we’d be looking at a forward yield of around 5.3% at a current share price of 213p.

G A Chester has no position in any shares mentioned. The Motley Fool UK has recommended HSBC Holdings. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Up 50% in a year! Now check out the intriguing BP share price forecast for the next 12 months

The BP share price is up one day, down the next, as geopolitical uncertainty rattles the FTSE 100. Harvey Jones…

Read more »

Investing Articles

Is now the perfect time to buy high-yield FTSE 100 dividend shares? 

Harvey Jones says UK dividend shares have a brilliant track record of delivering income and growth, and he can see…

Read more »

Bronze bull and bear figurines
Investing Articles

At 7,000 points, the S&P 500 looks bloated. How should investors navigate this market?

AI-hype may have ballooned the S&P 500 into the mother of all bubbles – but only time will tell. For…

Read more »

Smart young brown businesswoman working from home on a laptop
Investing Articles

How £100 can start a portfolio of UK stocks

Whether it’s building wealth or earning passive income, UK investors might be surprised at what £100 a month in stocks…

Read more »

Passive income text with pin graph chart on business table
Investing Articles

How £16,000 can generate a second income in a Stocks and Shares ISA

Stephen Wright explains how UK investors can target an immediate £1,224 annual second income from UK dividend shares with a…

Read more »

Bronze bull and bear figurines
Investing Articles

This crazy growth stock is up 97% inside 2 months in my ISA!

Hims & Hers Health (NYSE:HIMS) is both an exciting and incredibly volatile growth stock. What on earth has sent it…

Read more »

Woman riding her old fashioned bicycle along the Beach Esplanade at Aberdeen, Scotland.
Investing Articles

How to target a million-pound SIPP by investing in UK shares

Harvey Jones shows how investors could target a SIPP worth a life-changing seven-figure sum, by investing in FTSE 100 dividend…

Read more »

A rear view of a female in a bright yellow coat walking along the historic street known as The Shambles in York, UK which is a popular tourist destination in this Yorkshire city.
Investing Articles

Buying £20k of BAE Systems shares could give me a £360 income this year!

Looking for the best dividend stocks out there? Royston Wild explains why BAE Systems shares are worth considering.

Read more »